This randomized trial compares the efficacy and safety of tinzaparin vs warfarin for treatment of acute, symptomatic venous thromboembolism in patients with active cancer.
This randomized trial reports that, among overweight and obese participants with type 2 diabetes, use of daily liraglutide, a glucagon-like peptide 1 analog, resulted in weight loss over 56 weeks compared with placebo.
This cohort study used high school students’ responses to a substance use survey to evaluate whether baseline e-cigarette use among never-smoking adolescents is associated with starting to smoke cigarettes, cigars, or hookah water pipes.
This study used data from the 2008-2012 American Community Survey to investigate the association between legalizing same-sex marriage in New York and changes in health insurance coverage.
This Viewpoint discusses the threats to public health from e-cigarettes specific to developing countries and urges governments and nongovernmental organizations to control their spread.
This Viewpoint summarizes available insulin treatment regimens and the rationale for using each and proposes that treatment cost should be a factor in choosing which to use.
In light of the King v Burell decision, this Viewpoint urges state legislators to look at the options and data before they leap into state-based marketplaces as part of the Affordable Care Act program.
This Viewpoint explains the concept of narrow networks and the Affordable Care Act.
This narrative review summarizes advances in the diagnosis and treatment of septic shock between 2010-2015.
This editorial interprets a JAMA Internal Medicine randomized trial comparing durations of long-term nicotine patch treatment in the context of prior research evaluating smoking cessation treatments.
This Clinical Evidence Synopsis summarizes a recent Cochrane Review comparing the risk of hyponatraemia with isotonic vs hypotonic intravenous fluid for maintenance hydration in children.
This Medical Letter on Drugs and Therapeutics article provides information about sacubitril/valsartan, a recently approved fixed-dose combination medication for patients with heart failure and reduced ejection fraction.
This Medical News and Perspectives article discusses research that investigates whether statins may help reduce the risk of cardiovascular disease associated with HIV infection.